A detailed history of Ogorek Anthony Joseph transactions in Amgen Inc stock. As of the latest transaction made, Ogorek Anthony Joseph holds 221 shares of AMGN stock, worth $64,974. This represents 0.02% of its overall portfolio holdings.

Number of Shares
221
Previous 219 0.91%
Holding current value
$64,974
Previous $68,000 4.41%
% of portfolio
0.02%
Previous 0.02%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$309.38 - $337.38 $618 - $674
2 Added 0.91%
221 $71,000
Q2 2024

Aug 08, 2024

BUY
$262.75 - $319.31 $262 - $319
1 Added 0.46%
219 $68,000
Q1 2024

May 03, 2024

SELL
$268.87 - $324.56 $2,688 - $3,245
-10 Reduced 4.39%
218 $61,000
Q3 2023

Oct 19, 2023

BUY
$218.65 - $271.46 $2,186 - $2,714
10 Added 4.59%
228 $61,000
Q1 2023

May 03, 2023

BUY
$225.79 - $275.2 $49,222 - $59,993
218 New
218 $52,000
Q2 2020

Aug 07, 2020

SELL
$197.81 - $242.74 $9,890 - $12,137
-50 Closed
0 $0
Q4 2019

Jan 21, 2020

BUY
$189.21 - $243.2 $9,460 - $12,160
50 New
50 $12,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ogorek Anthony Joseph Portfolio

Follow Ogorek Anthony Joseph and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ogorek Anthony Joseph , based on Form 13F filings with the SEC.

News

Stay updated on Ogorek Anthony Joseph with notifications on news.